Blood Res  
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
Pasquale Niscola1, Carmen Di Grazia2, Carla Mazzone1, Barbara Tolu3, Paolo de Fabritiis1, Emanuele Angelucci2
1Hematology Unit, Saint Eugenio Hospital, Tor Vergata University, Rome, 2Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genua, 3Radiation Oncology Unit, UPMC Hillman Cancer Center, San Pietro Hospital FBF, Rome, Italy
Correspondence to: Pasquale Niscola M.D.
Hematology Unit, Saint Eugenio Hospital, Piazzale dell’Umanesimo 10, Roma 00144, Italia
Published online: December 11, 2019.
© The Korean Journal of Hematology. All rights reserved.


This Article

Current Issue


Indexed/Covered by

Today : 154  /
Total : 176,559